W. Herbert Haught

2.3k total citations · 1 hit paper
15 papers, 1.3k citations indexed

About

W. Herbert Haught is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, W. Herbert Haught has authored 15 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Surgery. Recurrent topics in W. Herbert Haught's work include Heart Failure Treatment and Management (5 papers), Electrolyte and hormonal disorders (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). W. Herbert Haught is often cited by papers focused on Heart Failure Treatment and Management (5 papers), Electrolyte and hormonal disorders (4 papers) and Nitric Oxide and Endothelin Effects (2 papers). W. Herbert Haught collaborates with scholars based in United States, Czechia and Bulgaria. W. Herbert Haught's co-authors include Uri Elkayam, Darlene P. Horton, William T. Abraham, Thierry H. LeJemtel, Lynne E. Wagoner, Allen D. Johnson, Michael M. Givertz, Robert C. Bourge, Chang‐seng Liang and Wilson S. Colucci and has published in prestigious journals such as New England Journal of Medicine, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

W. Herbert Haught

15 papers receiving 1.3k citations

Hit Papers

Intravenous Nesiritide, a Natriuretic Peptide, in the Tre... 2000 2026 2008 2017 2000 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. Herbert Haught United States 9 871 378 220 215 129 15 1.3k
Geoffrey Berg United Kingdom 18 524 0.6× 234 0.6× 142 0.6× 456 2.1× 97 0.8× 55 1.2k
Takashi Tsutsui Japan 15 1.3k 1.5× 187 0.5× 256 1.2× 324 1.5× 86 0.7× 25 1.7k
Enrico Mangieri Italy 20 898 1.0× 356 0.9× 132 0.6× 327 1.5× 42 0.3× 69 1.5k
B. Jackson Australia 21 664 0.8× 312 0.8× 279 1.3× 237 1.1× 80 0.6× 57 1.5k
Mary Lee Myers Canada 21 722 0.8× 219 0.6× 254 1.2× 383 1.8× 104 0.8× 40 1.7k
Li‐Ming Gan Sweden 27 1.3k 1.5× 165 0.4× 254 1.2× 313 1.5× 64 0.5× 71 1.8k
H Just Germany 13 620 0.7× 153 0.4× 154 0.7× 213 1.0× 58 0.4× 38 1.2k
G. Riegger Germany 21 579 0.7× 191 0.5× 250 1.1× 271 1.3× 44 0.3× 56 1.4k
Peder L. Myhre Norway 19 934 1.1× 178 0.5× 216 1.0× 251 1.2× 56 0.4× 93 1.6k
P Milliez France 19 489 0.6× 275 0.7× 174 0.8× 195 0.9× 26 0.2× 93 1.4k

Countries citing papers authored by W. Herbert Haught

Since Specialization
Citations

This map shows the geographic impact of W. Herbert Haught's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Herbert Haught with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Herbert Haught more than expected).

Fields of papers citing papers by W. Herbert Haught

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. Herbert Haught. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Herbert Haught. The network helps show where W. Herbert Haught may publish in the future.

Co-authorship network of co-authors of W. Herbert Haught

This figure shows the co-authorship network connecting the top 25 collaborators of W. Herbert Haught. A scholar is included among the top collaborators of W. Herbert Haught based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. Herbert Haught. W. Herbert Haught is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Konstam, Marvin A., Michael S. Kiernan, A. Bleakley Chandler, et al.. (2016). Acute Effect of the V2 Receptor Blocker, Tolvaptan, on Dyspnea in Patients Hospitalized with Heart Failure: Results of the SECRET of CHF. Journal of Cardiac Failure. 22(11). 939–939. 2 indexed citations
2.
Udelson, James E., Cesare Orlandi, John Ouyang, et al.. (2008). Acute Hemodynamic Effects of Tolvaptan, a Vasopressin V2 Receptor Blocker, in Patients With Symptomatic Heart Failure and Systolic Dysfunction. Journal of the American College of Cardiology. 52(19). 1540–1545. 139 indexed citations
3.
Goldsmith, Steven R., Uri Elkayam, W. Herbert Haught, Abhijit Barve, & Weizhong He. (2008). Efficacy and Safety of the Vasopressin V1A/V2-Receptor Antagonist Conivaptan in Acute Decompensated Heart Failure: A Dose-Ranging Pilot Study. Journal of Cardiac Failure. 14(8). 641–647. 74 indexed citations
5.
Colucci, Wilson S., Uri Elkayam, Darlene P. Horton, et al.. (2000). Intravenous Nesiritide, a Natriuretic Peptide, in the Treatment of Decompensated Congestive Heart Failure. New England Journal of Medicine. 343(4). 246–253. 669 indexed citations breakdown →
6.
Elkayam, Uri, et al.. (1998). Safety study of nesiritide (human b-type natriuretic peptide) for the treatment of hospitalized patients with acutely decompensated CHF. Journal of Cardiac Failure. 4(3). 40–40. 4 indexed citations
7.
Chen, Liying, et al.. (1997). Preservation of Endogenous Antioxidant Activity and Inhibition of Lipid Peroxidation as Common Mechanisms of Antiatherosclerotic Effects of Vitamin E, Lovastatin and Amlodipine. Journal of the American College of Cardiology. 30(2). 569–575. 177 indexed citations
8.
Mills, Roger M. & W. Herbert Haught. (1996). Evaluation of heart failure patients: Objective parameters to assess functional capacity. Clinical Cardiology. 19(6). 455–460. 30 indexed citations
9.
Lawson, Daniel, W. Herbert Haught, Paulette Mehta, & Jawahar L. Mehta. (1996). Studies of Vascular Tolerance to Nitroglycerin: Effects of N-Acetylcysteine, NG-Monomethyl L-Arginine, and Endothelin-1. Journal of Cardiovascular Pharmacology. 28(3). 418–424. 3 indexed citations
10.
Haught, W. Herbert, Michael Mansour, Robert Rothlein, et al.. (1996). Alterations in circulating intercellular adhesion molecule-1 and L-selectin: Further evidence for chronic inflammation in ischemic heart disease. American Heart Journal. 132(1). 1–8. 165 indexed citations
11.
Haught, W. Herbert, et al.. (1995). Decrease in hematocrit after coronary stent placement and dextran therapy. The American Journal of Cardiology. 76(4). 314–315. 8 indexed citations
12.
Haught, W. Herbert, Barry Bertolet, Jamie B. Conti, Anne B. Curtis, & Roger M. Mills. (1994). Theophylline reverses high-grade atrioventricular block resulting from cardiac transplant rejection. American Heart Journal. 128(6). 1255–1257. 17 indexed citations
13.
Haught, W. Herbert, et al.. (1993). Case Report: Bacillary Angiomatosis with Massive Visceral Lymphadenopathy. The American Journal of the Medical Sciences. 306(4). 236–240. 11 indexed citations
14.
Haught, W. Herbert, et al.. (1991). Familial recurring cardiac myxoma. Clinical Cardiology. 14(8). 692–695. 5 indexed citations
15.
Mehta, J. L., Daniel Lawson, Baichun Yang, W. Herbert Haught, & Thomas H. Hintze. (1991). Role of superoxide radicals in anoxia and reoxygenation-mediated vascular contraction. Life Sciences. 49(23). 1739–1746. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026